ConductScience.org, home

Gene · 9493

KIF23: kinesin family member 23

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. KIF23: kinesin family member 23. Genes, record 9493. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9493

On this page

Gene

Symbol
KIF23
HGNC
Name
kinesin family member 23
HGNC
NCBI Gene ID
9493
NCBI Gene
HGNC ID
HGNC:6392
HGNC
Ensembl
ENSG00000137807
NCBI Gene
Aliases
CDA3, CDAIII, CDAN3, CDAN3A, CHO1, KNSL5, MKLP-1, MKLP1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q02241Kinesin-like protein KIF239601Ensembl, GeneID, HGNC

Source UniProt

Patents23

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1450855Q02241Espacenet
EP 4650780 A22025-11-191799Q02241Espacenet
EP 4641201 A22025-10-291383Q02241Espacenet
EP 4641202 A22025-10-294505Q02241Espacenet
JP 2025517969 A2025-06-121383Q02241Espacenet
JP 2025517970 A2025-06-121799Q02241Espacenet
KR 1020250017231 A2025-02-044505Q02241Espacenet
US 11446398 B22022-09-2044287Q02241Espacenet
JP 2022524081 A2022-04-27147258Q02241Espacenet
JP 2019054813 A2019-04-11231290Q02241Espacenet

1 to 10 of 23

See all 23 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants811

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleKIF23 papersNewest fiscal year
R01DK064380Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis62025
P40OD010440Caenorhabditis Genetics Center42025
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)32025
P30CA014520UW Comprehensive Cancer Center Support32025
P30CA068485Cancer Center Support Grant32025
R01DK103794Systematic Genetic Dissection of Human Erythropoiesis32025
P30CA012197Cancer Center Support Grant22025
P30CA013148Comprehensive Cancer Center Support Grant22025
P30CA015704Cancer Center Support Grant22025
P30CA016056Roswell Park Cancer Center Support Grant22025

1 to 10 of 811Source NIH's project files

See all 811 nih grants

Papers1,622

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
USP36-mediated stabilization of NAT10 promotes osteosarcoma progression via ac4C-dependent KIF23 mRNA stabilization.Biochim Biophys Acta Mol Basis Dis202642826871PubTator, text miningPubMed
Study on the potential role of KIF23 in doxorubicin-induced cardiomyopathy through multi-omics integration and AI-based screening.Comput Biol Chem202642567083PubTator, text miningPubMed
LncRNA ABCA9-AS1 as a ceRNA Promotes Gastric Cancer Progression by Sponging miR-497-5p to Regulate KIF23 Expression.Curr Cancer Drug Targets202642515901PubTator, text miningPubMed
Retraction notice to "Molecular structure of polysaccharide mediated autophagy markers KIF23 and PRC1 proteins and their regulatory role in triple negative cancer through the p53 signaling pathway" [Int. J. Biol. Macromol. 291 (2025) 139155].
Int J Biol Macromol202642481345PubTator, text miningPubMed
Targeting Sirtuins in Thyroid Cancer: Mechanisms, Drug Development, and Emerging Roles in Tumor Immunity and Ferroptosis.Cancers (Basel)202642449637PubTator, text miningPubMed
The NLRP3 inflammasome in gynecological cancers: a double-edged sword shaping the immune microenvironment and immunotherapy response.Front Immunol202642421965PubTator, text miningPubMed
KIF23 in disease pathogenesis and therapeutics : from molecular mechanisms to clinical translation.Cancer Cell Int202642410612PubTator, text miningPubMed
Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study.World J Surg Oncol202642365339PubTator, text miningPubMed
The role of KIF23 in cancer: From molecular insights to therapeutic approaches.Gene202642288227PubTator, text miningPubMed
KIF11 drives ovarian cancer progression and cisplatin resistance via the Wnt/β-catenin signaling pathway.Biochem Biophys Res Commun202642263603PubTator, text miningPubMed

1 to 10 of 1,622

See all 1,622 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/9493

GET https://conductscience.org/api/genes/v1/9493/patents?page=2